A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In a report released today, Emily Field from Barclays maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of ...

AstraZeneca Plc reported better-than-expected profit and sales in the fourth quarter and forecast further gains as the UK drugmaker’s blockbuster cancer drugs offset weakened China sales.

In early UK corporate news, AstraZeneca reported earnings growth, Compass backed its outlook and Babcock raised its expectations. Elsewhere, BBGI Global Infrastructure backed a takeover offer. Here is ...

In a report released today, James Gordon from J.P. Morgan maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target ...

Quantum computing is shaping up to be the next big investing revolution, and for a very good reason. With the power to solve ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

If an investor was to purchase shares of AZN stock at the current price level of $70.69/share, and then sell-to-open that call contract as a "covered call," they are committing to sell the stock ...

As on 31-12-2024, the company has a total of 2.50 Crore shares outstanding.AstraZeneca Share Price Today is Rs. 7410.30. On previous day, the AstraZeneca Share Price (NSE) closed at Rs. 7262.8, ...